Humana Inc. to Release Fourth Quarter 2010 Results on February 7, 2011

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2010 on Monday, February 7, 2011 at 6:00 a.m. eastern time. The company will host a conference call, as well as a virtual slide presentation at 9:00 a.m. eastern time that same morning to discuss its financial results for the quarter.

The live virtual presentation (audio with slides) on February 7 may be accessed via Humana’s Investor Relations page at www.humana.com. The company suggests web participants sign on approximately 15 minutes in advance of the call. The company also suggests web participants visit the site well in advance of the call to run a system test and to download any free software needed to view the presentation.

All parties interested in the audio only portion of the February 7 conference call are invited to dial 888-625-7430. No password is required. The company suggests participants dial in approximately ten minutes in advance of the call.

For those unable to participate in the live event on February 7, the virtual presentation archive will be available in the Presentations section of the Investor Relations page at www.humana.com, approximately two hours following the live webcast. Telephone replays will be available from 12:00 p.m. eastern time on February 7, 2011 until midnight eastern time on February 9, 2011 and can be accessed by dialing 800-642-1687 and providing the conference ID #49460908.

The company’s fourth quarter 2010 earnings news release may include financial measures that are not in accordance with Generally Accepted Accounting Principles (“GAAP”). A reconciliation of these non-GAAP financial measures to financial results under GAAP, as well as management’s reasons for including the non-GAAP financial measures, will be included in the company’s fourth quarter 2010 earnings news release, a copy of which will be available on the Investor Relations page of www.humana.com on February 7, 2011.

Humana Inc., headquartered in Louisville, Kentucky, is one of the nation’s largest publicly traded health and supplemental benefits companies, with approximately 10.1 million medical members, 7.0 million specialty members, and operates more than 300 medical centers and 240 worksite medical facilities. Humana is a full-service benefits and well-being solutions company, offering a wide array of health, pharmacy and supplemental benefit plans for employer groups, government programs and individuals, as well as primary and workplace care through its medical centers and worksite medical facilities.

Over its 50-year history, Humana has consistently seized opportunities to meet changing customer needs. Today, the company is a leader in consumer engagement, providing guidance that leads to lower costs and a better health plan experience throughout its diversified customer portfolio.

More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:

  • Annual reports to stockholders;
  • Securities and Exchange Commission filings;
  • Most recent investor conference presentations;
  • Quarterly earnings news releases;
  • Replays of most recent earnings release conference calls;
  • Calendar of events (including upcoming earnings conference call dates and times, as well as planned interaction with research analysts and institutional investors);
  • Corporate Governance information.



CONTACT:

Humana Inc.
Investor Relations:
Regina Nethery, 502-580-3644
[email protected]
or
Corporate Communications:
Tom Noland, 502-580-3674
[email protected]

KEYWORDS:   United States  North America  Kentucky

INDUSTRY KEYWORDS:   Health  Professional Services  Insurance  General Health  Managed Care

MEDIA:

Logo
 Logo

Suggested Articles

Humana filed suit Friday against more than a dozen generic drugmakers alleging the companies engaged in price fixing.

Medicare Advantage open enrollment kicked off last week, and insurers are taking new approaches to marketing a slate of supplemental benefit options. 

Centene announced another five states have approved its pending $17B merger with WellCare, bringing total number of approvals to 24.